Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.1532
-0.0125 (-7.54%)
At close: Oct 28, 2026, 4:00 PM EDT
0.1500
-0.0032 (-2.09%)
After-hours: Oct 28, 2026, 4:06 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $851.83 thousand as of October 28, 2026. It is the 49,576th most valuable company in the world and the 6,740th biggest in the United States. Its market cap has decreased by 57.64% in one year.
Market Cap
851.83K
Enterprise Value
32.83K
1-Year Change
-57.64%
Global Rank
Country Rank
#6,740 United States
Category
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $851.83K, a decrease of -99.43%. That is a compound annual growth rate of -60.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 851.83K | -85.81% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 1.48M |
| Propanc Biopharma | 1.45M |
| Lunai Bioworks | 1.38M |
| Jaguar Health | 1.23M |
| Artelo Biosciences | 1.21M |
| Bone Biologics | 1.04M |
| Endovia Health Sciences | 1.01M |
| Virax Biolabs Group | 948.42K |